We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.1B
AUM Growth
+$134M
(+0.89%)
Cap. Flow
-$3.91B
Cap. Flow
% of AUM
-25.89%
Top 10 Holdings %
Top 10 Hldgs %
18.53%
Holding
722
New
62
Increased
243
Reduced
170
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$92.3M |
| 2 |
Microsoft
MSFT
|
+$73.7M |
| 3 |
ExxonMobil
XOM
|
+$73.7M |
| 4 |
Starbucks
SBUX
|
+$72.3M |
| 5 |
Procter & Gamble
PG
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLU
METLIFE, INC. COM EQUITY UNIT
MLU
|
+$130M |
| 2 |
SLB Ltd
SLB
|
+$108M |
| 3 |
UTX.PRA
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
|
+$82M |
| 4 |
Eaton
ETN
|
+$72.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.08% |
| 2 | Technology | 11.12% |
| 3 | Healthcare | 9.42% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRXL
126
DELISTED
Parexel International Corp
PRXL
| $22.7M | 0.15% |
407,770
+189,237
| +87% | +$10.9M |
|
|
BEAV
127
DELISTED
B/E Aerospace Inc
BEAV
| $22.4M | 0.15% |
386,650
-129,542
| -25% | -$7.22M |
|
128
Visa
V
$677B
| $22M | 0.15% |
335,340
-78,260
| -19% | -$4.71M |
|
129
Intel
INTC
$466B
| $20.5M | 0.14% |
565,222
-58,353
| -9% | -$2.03M |
|
|
BRCM
130
DELISTED
BROADCOM CORP CL-A
BRCM
| $20.4M | 0.13% |
470,300
-1,395
| -0.3% | -$57.2K |
|
131
Walmart Inc
WMT
$871B
| $20.1M | 0.13% |
701,844
+3,144
| +0.4% | +$85K |
|
132
McDonald's
MCD
$188B
| $19.1M | 0.13% |
204,165
+365
| +0.2% | +$34.2K |
|
133
Bank of America Series L
BAC.PRL
$3.95B
| $18.4M | 0.12% |
+15,824
| New | +$18.3M |
|
|
INVN
134
DELISTED
Invensense Inc
INVN
| $18.2M | 0.12% |
1,119,231
+9,931
| +0.9% | +$167K |
|
135
IBM
IBM
$202B
| $18.2M | 0.12% |
118,359
+18,780
| +19% | +$2.99M |
|
|
PARA
136
DELISTED
Paramount Global Class B
PARA
| $18M | 0.12% |
325,341
-89,820
| -22% | -$4.78M |
|
137
Ford
F
$57.3B
| $17.9M | 0.12% |
1,156,108
+2,108
| +0.2% | +$31.1K |
|
138
NOV
NOV
$7.45B
| $17.9M | 0.12% |
272,815
-237,313
| -47% | -$16.5M |
|
|
MLNX
139
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $17.8M | 0.12% |
416,360
+54,860
| +15% | +$2.38M |
|
140
Antero Resources
AR
$10.9B
| $17.4M | 0.12% |
428,515
-36,778
| -8% | -$1.76M |
|
141
Nokia
NOK
$50.8B
| $17.3M | 0.11% |
2,200,000
| – | – |
|
142
AbbVie
ABBV
$458B
| $16.9M | 0.11% |
257,665
+13,565
| +6% | +$855K |
|
143
US Bancorp
USB
$99.6B
| $16.7M | 0.11% |
370,926
+1,926
| +0.5% | +$82.9K |
|
144
TJX Companies
TJX
$170B
| $16.4M | 0.11% |
478,942
+742
| +0.2% | +$23.6K |
|
|
BERY
145
DELISTED
Berry Global Group, Inc.
BERY
| $16.1M | 0.11% |
+554,146
| New | +$13.9M |
|
|
CAM
146
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $15.6M | 0.1% |
312,371
-60,993
| -16% | -$3.38M |
|
147
Norwegian Cruise Line
NCLH
$8.89B
| $15.4M | 0.1% |
329,619
+186,518
| +130% | +$7.49M |
|
|
VSI
148
DELISTED
Vitamin Shoppe Inc.
VSI
| $15.4M | 0.1% |
316,059
+81,215
| +35% | +$3.73M |
|
149
CVS Health
CVS
$137B
| $15.1M | 0.1% |
157,015
+815
| +0.5% | +$71.8K |
|
150
Amgen
AMGN
$203B
| $14.8M | 0.1% |
93,116
+416
| +0.4% | +$64.8K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Calamos Advisors held 722 positions worth $15.1B, up 0.89% from $15B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Calamos Advisors withdrew a net $3.91B in Q4 2014, closing 71 positions and reducing 170 holdings. Its most notable exit was METLIFE, INC. COM EQUITY UNIT, an estimated $130M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Northrop Grumman worth $29.4M.
- Calamos Advisors's largest Q4 2014 buy was Northrop Grumman: 199,438 shares worth $29.4M.
- Calamos Advisors added most to MetLife in Q4 2014, an estimated $92.3M increase.
- Calamos Advisors's biggest Q4 2014 reduction was SLB Ltd, cutting an estimated $108M.
- Calamos Advisors fully exited METLIFE, INC. COM EQUITY UNIT in Q4 2014, selling an estimated $130M.
- Calamos Advisors's ten largest holdings make up 19% of its $15.1B portfolio in Q4 2014.
- Calamos Advisors opened 62 new positions and closed 71 in Q4 2014.
- Calamos Advisors's portfolio value rose 0.89% quarter-over-quarter to $15.1B.
Based on Calamos Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.